{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T18:41:43Z","timestamp":1793990503041,"version":"4.8.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T00:00:00Z","timestamp":1560124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T00:00:00Z","timestamp":1560124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802911"],"award-info":[{"award-number":["81802911"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472240, 8177110562"],"award-info":[{"award-number":["81472240, 8177110562"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["16411952700, 10411955400, 09411960800"],"award-info":[{"award-number":["16411952700, 10411955400, 09411960800"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Outstanding Academic Leaders Plan","award":["2016"],"award-info":[{"award-number":["2016"]}]},{"DOI":"10.13039\/501100010167","name":"Shanghai Shen Kang Hospital Development Center","doi-asserted-by":"publisher","award":["16CR2002A"],"award-info":[{"award-number":["16CR2002A"]}],"id":[{"id":"10.13039\/501100010167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010167","name":"Shanghai Shen Kang Hospital Development Center","doi-asserted-by":"publisher","award":["16CR3028A"],"award-info":[{"award-number":["16CR3028A"]}],"id":[{"id":"10.13039\/501100010167","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13046-019-1250-8","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T15:02:53Z","timestamp":1560178973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR\/CCL2 pathway"],"prefix":"10.1186","volume":"38","author":[{"given":"Hui","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruirong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunwang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xince","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,10]]},"reference":[{"key":"1250_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277\u2013300.","journal-title":"CA Cancer J Clin"},{"key":"1250_CR2","first-page":"99","volume":"6","author":"R Hundal","year":"2014","unstructured":"Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99\u2013109.","journal-title":"Clin Epidemiol"},{"key":"1250_CR3","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/j.1440-1746.2011.07048.x","volume":"27","author":"U Dutta","year":"2012","unstructured":"Dutta U. Gallbladder cancer: can newer insights improve the outcome? J Gastroenterol Hepatol. 2012;27:642\u201353.","journal-title":"J Gastroenterol Hepatol"},{"key":"1250_CR4","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.ejso.2009.02.005","volume":"35","author":"C Pilgrim","year":"2009","unstructured":"Pilgrim C, Usatoff V, Evans PM. A review of the surgical strategies for the management of gallbladder carcinoma based on T stage and growth type of the tumour. Eur J Surg Oncol. 2009;35:903\u20137.","journal-title":"Eur J Surg Oncol"},{"key":"1250_CR5","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/(SICI)1097-0142(19970815)80:4<661::AID-CNCR3>3.0.CO;2-Q","volume":"80","author":"K Tsukada","year":"1997","unstructured":"Tsukada K, Kurosaki I, Uchida K, Shirai Y, Oohashi Y, Yokoyama N, Watanabe H, Hatakeyama K. Lymph node spread from carcinoma of the gallbladder. Cancer. 1997;80:661\u20137.","journal-title":"Cancer"},{"key":"1250_CR6","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/jso.20537","volume":"93","author":"MC Misra","year":"2006","unstructured":"Misra MC, Guleria S. Management of cancer gallbladder found as a surprise on a resected gallbladder specimen. J Surg Oncol. 2006;93:690\u20138.","journal-title":"J Surg Oncol"},{"key":"1250_CR7","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/gut.38.3.426","volume":"38","author":"T Ajiki","year":"1996","unstructured":"Ajiki T, Fujimori T, Onoyama H, Yamamoto M, Kitazawa S, Maeda S, Saitoh Y. K-ras gene mutation in gall bladder carcinomas and dysplasia. Gut. 1996;38:426\u20139.","journal-title":"Gut"},{"key":"1250_CR8","doi-asserted-by":"publisher","first-page":"21515","DOI":"10.1074\/jbc.274.31.21515","volume":"274","author":"MH Hu","year":"1999","unstructured":"Hu MH, Bauman EM, Roll RL, Yeilding N, Abrams CS. Pleckstrin 2, a widely expressed paralog of pleckstrin involved in actin rearrangement. J Biol Chem. 1999;274:21515\u20138.","journal-title":"J Biol Chem"},{"key":"1250_CR9","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1182\/blood-2006-02-001339","volume":"109","author":"TL Bach","year":"2007","unstructured":"Bach TL, Kerr WT, Wang Y, Bauman EM, Kine P, Whiteman EL, Morgan RS, Williamson EK, Ostap EM, Burkhardt JK, et al. PI3K regulates pleckstrin-2 in T-cell cytoskeletal reorganization. Blood. 2007;109:1147\u201355.","journal-title":"Blood"},{"key":"1250_CR10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.bbrc.2007.06.132","volume":"361","author":"N Hamaguchi","year":"2007","unstructured":"Hamaguchi N, Ihara S, Ohdaira T, Nagano H, Iwamatsu A, Tachikawa H, Fukui Y. Pleckstrin-2 selectively interacts with phosphatidylinositol 3-kinase lipid products and regulates actin organization and cell spreading. Biochem Biophys Res Commun. 2007;361:270\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"1250_CR11","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.molonc.2007.03.004","volume":"1","author":"B Naume","year":"2007","unstructured":"Naume B, Zhao X, Synnestvedt M, Borgen E, Russnes HG, Lingjaerde OC, Stromberg M, Wiedswang G, Kvalheim G, Karesen R, et al. Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer. Mol Oncol. 2007;1:160\u201371.","journal-title":"Mol Oncol"},{"key":"1250_CR12","doi-asserted-by":"publisher","first-page":"e20971","DOI":"10.1371\/journal.pone.0020971","volume":"6","author":"Y Luo","year":"2011","unstructured":"Luo Y, Robinson S, Fujita J, Siconolfi L, Magidson J, Edwards CK, Wassmann K, Storm K, Norris DA, Bankaitis-Davis D, et al. Transcriptome profiling of whole blood cells identifies PLEK2 and C1QB in human melanoma. PLoS One. 2011;6:e20971.","journal-title":"PLoS One"},{"key":"1250_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S1097-2765(03)00350-2","volume":"12","author":"AW Burgess","year":"2003","unstructured":"Burgess AW, Cho HS, Eigenbrot C, Ferguson KM, Garrett TP, Leahy DJ, Lemmon MA, Sliwkowski MX, Ward CW, Yokoyama S. An open-and-shut case? Recent insights into the activation of EGF\/ErbB receptors. Mol Cell. 2003;12:541\u201352.","journal-title":"Mol Cell"},{"key":"1250_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1055-3207(18)30065-6","volume":"10","author":"L Lamorte","year":"2001","unstructured":"Lamorte L, Park M. The receptor tyrosine kinases: role in cancer progression. Surg Oncol Clin N Am. 2001;10:271\u201388 viii.","journal-title":"Surg Oncol Clin N Am"},{"key":"1250_CR15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2174\/1568026618666180329123023","volume":"18","author":"R Concu","year":"2018","unstructured":"Concu R, Cordeiro M. Looking for new inhibitors for the epidermal growth factor receptor. Curr Top Med Chem. 2018;18:219\u201332.","journal-title":"Curr Top Med Chem"},{"key":"1250_CR16","doi-asserted-by":"publisher","first-page":"E973","DOI":"10.1152\/ajpendo.90857.2008","volume":"296","author":"JV Abella","year":"2009","unstructured":"Abella JV, Park M. Breakdown of endocytosis in the oncogenic activation of receptor tyrosine kinases. Am J Physiol Endocrinol Metab. 2009;296:E973\u201384.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"11","key":"1250_CR17","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3390\/cells7110212","volume":"7","author":"Tatsuya Nagano","year":"2018","unstructured":"Nagano T, Tachihara M, Nishimura Y. Mechanism of resistance to epidermal growth factor receptor-tyrosine kinase inhibitors and a potential treatment strategy. Cells. 2018;7.","journal-title":"Cells"},{"key":"1250_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1615\/CritRevOncog.v17.i1.40","volume":"17","author":"NS Dhomen","year":"2012","unstructured":"Dhomen NS, Mariadason J, Tebbutt N, Scott AM. Therapeutic targeting of the epidermal growth factor receptor in human cancer. Crit Rev Oncog. 2012;17:31\u201350.","journal-title":"Crit Rev Oncog"},{"key":"1250_CR19","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1172\/JCI32278","volume":"117","author":"H Zhang","year":"2007","unstructured":"Zhang H, Berezov A, Wang Q, Zhang G, Drebin J, Murali R, Greene MI. ErbB receptors: from oncogenes to targeted cancer therapies. J Clin Invest. 2007;117:2051\u20138.","journal-title":"J Clin Invest"},{"key":"1250_CR20","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1038\/nm.3388","volume":"19","author":"CR Chong","year":"2013","unstructured":"Chong CR, Janne PA. The quest to overcome resistance to EGFR-targeted therapies in cancer. Nat Med. 2013;19:1389\u2013400.","journal-title":"Nat Med"},{"key":"1250_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41419-017-0107-3","volume":"9","author":"H Shen","year":"2018","unstructured":"Shen H, Zhan M, Zhang Y, Huang S, Xu S, Huang X, He M, Yao Y, Man M, Wang J. PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2. Cell Death Dis. 2018;9:71.","journal-title":"Cell Death Dis"},{"key":"1250_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1742-4658.2009.07448.x","volume":"277","author":"T Mitsudomi","year":"2010","unstructured":"Mitsudomi T, Yatabe Y. Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer. FEBS J. 2010;277:301\u20138.","journal-title":"FEBS J"},{"key":"1250_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0014-4827(02)00098-8","volume":"284","author":"RN Jorissen","year":"2003","unstructured":"Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, Burgess AW. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res. 2003;284:31\u201353.","journal-title":"Exp Cell Res"},{"key":"1250_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cytogfr.2009.11.009","volume":"21","author":"J Zhang","year":"2010","unstructured":"Zhang J, Patel L, Pienta KJ. CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis. Cytokine Growth Factor Rev. 2010;21:41\u20138.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1250_CR25","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1158\/0008-5472.CAN-15-2973","volume":"76","author":"X Yang","year":"2016","unstructured":"Yang X, Lin Y, Shi Y, Li B, Liu W, Yin W, Dang Y, Chu Y, Fan J, He R. FAP promotes immunosuppression by Cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling. Cancer Res. 2016;76:4124\u201335.","journal-title":"Cancer Res"},{"key":"1250_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10555-008-9169-0","volume":"28","author":"M Yilmaz","year":"2009","unstructured":"Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 2009;28:15\u201333.","journal-title":"Cancer Metastasis Rev"},{"key":"1250_CR27","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1615\/CritRevOncog.2014011802","volume":"19","author":"L Ombrato","year":"2014","unstructured":"Ombrato L, Malanchi I. The EMT universe: space between cancer cell dissemination and metastasis initiation. Crit Rev Oncog. 2014;19:349\u201361.","journal-title":"Crit Rev Oncog"},{"key":"1250_CR28","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/S1097-2765(00)80231-2","volume":"4","author":"G Levkowitz","year":"1999","unstructured":"Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, Alroy I, Lavi S, Iwai K, Reiss Y, Ciechanover A, et al. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl\/Sli-1. Mol Cell. 1999;4:1029\u201340.","journal-title":"Mol Cell"},{"key":"1250_CR29","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1101\/gad.12.23.3663","volume":"12","author":"G Levkowitz","year":"1998","unstructured":"Levkowitz G, Waterman H, Zamir E, Kam Z, Oved S, Langdon WY, Beguinot L, Geiger B, Yarden Y. C-Cbl\/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev. 1998;12:3663\u201374.","journal-title":"Genes Dev"},{"key":"1250_CR30","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/onc.2016.280","volume":"36","author":"J Hou","year":"2017","unstructured":"Hou J, Deng Q, Zhou J, Zou J, Zhang Y, Tan P, Zhang W, Cui H. CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR. Oncogene. 2017;36:1134\u201344.","journal-title":"Oncogene"},{"key":"1250_CR31","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1091\/mbc.e07-10-0988","volume":"19","author":"K Umebayashi","year":"2008","unstructured":"Umebayashi K, Stenmark H, Yoshimori T. Ubc4\/5 and c-Cbl continue to ubiquitinate EGF receptor after internalization to facilitate polyubiquitination and degradation. Mol Biol Cell. 2008;19:3454\u201362.","journal-title":"Mol Biol Cell"},{"key":"1250_CR32","doi-asserted-by":"publisher","first-page":"27456","DOI":"10.1074\/jbc.271.44.27456","volume":"271","author":"M Rojas","year":"1996","unstructured":"Rojas M, Yao S, Lin YZ. Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor. J Biol Chem. 1996;271:27456\u201361.","journal-title":"J Biol Chem"},{"key":"1250_CR33","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1128\/MCB.05647-11","volume":"32","author":"MN Okur","year":"2012","unstructured":"Okur MN, Ooi J, Fong CW, Martinez N, Garcia-Dominguez C, Rojas JM, Guy G, O'Bryan JP. Intersectin 1 enhances Cbl ubiquitylation of epidermal growth factor receptor through regulation of Sprouty2-Cbl interaction. Mol Cell Biol. 2012;32:817\u201325.","journal-title":"Mol Cell Biol"},{"key":"1250_CR34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/416183a","volume":"416","author":"P Soubeyran","year":"2002","unstructured":"Soubeyran P, Kowanetz K, Szymkiewicz I, Langdon WY, Dikic I. Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature. 2002;416:183\u20137.","journal-title":"Nature"},{"key":"1250_CR35","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/sj.embor.7400453","volume":"6","author":"K Haglund","year":"2005","unstructured":"Haglund K, Schmidt MHH, Wong ES, Guy GR, Dikic I. Sprouty2 acts at the Cbl\/CIN85 interface to inhibit epidermal growth factor receptor downregulation. EMBO Rep. 2005;6:635\u201341.","journal-title":"EMBO Rep"},{"key":"1250_CR36","doi-asserted-by":"publisher","first-page":"23317","DOI":"10.1074\/jbc.270.40.23317","volume":"270","author":"CS Abrams","year":"1995","unstructured":"Abrams CS, Zhao W, Belmonte E, Brass LF. Protein kinase C regulates pleckstrin by phosphorylation of sites adjacent to the N-terminal pleckstrin homology domain. J Biol Chem. 1995;270:23317\u201321.","journal-title":"J Biol Chem"},{"key":"1250_CR37","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/cmi.2017.135","volume":"15","author":"T Yoshimura","year":"2018","unstructured":"Yoshimura T. The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally? Cell Mol Immunol. 2018;15:335\u201345.","journal-title":"Cell Mol Immunol"},{"key":"1250_CR38","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1084\/jem.20141836","volume":"212","author":"T Kitamura","year":"2015","unstructured":"Kitamura T, Qian BZ, Soong D, Cassetta L, Noy R, Sugano G, Kato Y, Li J, Pollard JW. CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages. J Exp Med. 2015;212:1043\u201359.","journal-title":"J Exp Med"},{"key":"1250_CR39","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s10555-006-9027-x","volume":"25","author":"MJ Craig","year":"2006","unstructured":"Craig MJ, Loberg RD. CCL2 (monocyte chemoattractant Protein-1) in cancer bone metastases. Cancer Metastasis Rev. 2006;25:611\u20139.","journal-title":"Cancer Metastasis Rev"},{"key":"1250_CR40","first-page":"3299","volume":"35","author":"CC Lee","year":"2015","unstructured":"Lee CC, Ho HC, Su YC, Lee MS, Hung SK, Lin CH. MCP1-induced epithelial-mesenchymal transition in head and neck Cancer by AKT activation. Anticancer Res. 2015;35:3299\u2013306.","journal-title":"Anticancer Res"},{"key":"1250_CR41","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1021\/jf504934m","volume":"63","author":"YL Hsu","year":"2015","unstructured":"Hsu YL, Hung JY, Tsai YM, Tsai EM, Huang MS, Hou MF, Kuo PL. 6-shogaol, an active constituent of dietary ginger, impairs cancer development and lung metastasis by inhibiting the secretion of CC-chemokine ligand 2 (CCL2) in tumor-associated dendritic cells. J Agric Food Chem. 2015;63:1730\u20138.","journal-title":"J Agric Food Chem"},{"key":"1250_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2174\/156800913804486610","volume":"13","author":"Y Sun","year":"2013","unstructured":"Sun Y, Cheng MK, Griffiths TR, Mellon JK, Kai B, Kriajevska M, Manson MM. Inhibition of STAT signalling in bladder cancer by diindolylmethane: relevance to cell adhesion, migration and proliferation. Curr Cancer Drug Targets. 2013;13:57\u201368.","journal-title":"Curr Cancer Drug Targets"},{"key":"1250_CR43","doi-asserted-by":"crossref","unstructured":"Huang SY, Chang SF, Liao KF, Chiu SC. Tanshinone IIA inhibits epithelial-mesenchymal transition in bladder Cancer cells via modulation of STAT3-CCL2 signaling. Int J Mol Sci. 2017;18.","DOI":"10.3390\/ijms18081616"},{"key":"1250_CR44","first-page":"21","volume":"39","author":"H Zhuang","year":"2018","unstructured":"Zhuang H, Cao G, Kou C, Liu T. CCL2\/CCR2 axis induces hepatocellular carcinoma invasion and epithelial-mesenchymal transition in vitro through activation of the hedgehog pathway. Oncol Rep. 2018;39:21\u201330.","journal-title":"Oncol Rep"},{"key":"1250_CR45","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.prp.2016.12.013","volume":"213","author":"J Zhang","year":"2017","unstructured":"Zhang J, Yan Y, Cui X, Zhang J, Yang Y, Li H, Wu H, Li J, Wang L, Li M, et al. CCL2 expression correlates with Snail expression and affects the prognosis of patients with gastric cancer. Pathol Res Pract. 2017;213:217\u201321.","journal-title":"Pathol Res Pract"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1250-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-019-1250-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1250-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T23:27:23Z","timestamp":1591658843000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-019-1250-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,10]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1250"],"URL":"https:\/\/doi.org\/10.1186\/s13046-019-1250-8","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,10]]},"assertion":[{"value":"25 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was preceded in accordance with the standards of Institute Research Ethics Committee of Renji Hospital Hospital, and written informed consent to participate in this study was obtained from GBC patients and cholecystolithiasis patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to publish this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"247"}}